Table 24Summary of study characteristics of RCTs of physical activity versus no physical activity control, placebo and waitlist

GroupIndividualIndividual
Supervised aerobicSupervised non-aerobicSupervised aerobicSupervised non-aerobicUnsupervised aerobicUnsupervised non-aerobic
No. RCTs (No. of participants)5 (326)5 (252)4 (350)2 (404)1 (38)
Study IDs
N/% female/mean age
  1. 55/55/40
  2. 202/76/52
  3. 20/65/69
  4. 47/100/Not reported
  5. 82/81/82
  6. 124/64/36
  1. 46/74/50
  2. 86/69/65
  3. 32/63/71
  4. 32/53/71
  5. 60/55/69
  1. 80/75/36
  2. 202/76/52
  3. 38/55/50
  4. 30/?/73
  1. 202/76/52
  2. 202/76/52
  1. 38/55/74
Diagnosis (average baseline score)
  1. BDI >= 14 (BDI 25.0)
  2. MDD/subthreshold depressive symptoms/dysthymia (BDI 30.5)
  3. HRSD >= 10 (HRSD 18.13)
  4. BDI >= 11
  5. Features of depression/depression/dysthymia (GDS 5.8)
  6. CIS >= 17 (not reported)
  1. Dysthymia/depression/subthreshold depressive symptoms/mild depressive episode (not reported)
  2. Mood disorder (HRSD 17.1)
  3. MDD/subthreshold depressive symptoms/dysthymia (BDI 19.9)
  4. Major depression/subthreshold depressive symptoms/dysthymia (BDI 19.3)
  5. Major depression/MDD/subthreshold depressive symptoms/dysthymia (HRSD 19.1)
  1. Moderate depressive episode (HRSD 19.4)
  2. MDD/subthreshold depressive symptoms/dysthymia (not reported)
  3. Moderate depressive episode (CES-D 38.4)
  4. BDI >= 12 and <= 24 (not reported)
  1. MDD/subthreshold depressive symptoms/dysthymia (BDI 30.5)
  2. MDD/subthreshold depressive symptoms/dysthymia (not reported)
  1. GDS >= 11 (GDS 12.4)
Physical activity
  1. Water aerobics
  2. Walking/jogging
  3. Ballroom dancing
  4. Running
1.

Yoga

2–4.

Resistance training

5.

High- or low-intensity resistance training

  1. Treadmill/biking at different intensities/frequency
  2. Aerobics
  3. Treadmill
  4. Walking
  1. Walking/jogging
  2. Aerobics
Control
  1. Placebo pill
  2. Waitlist
  3. Newspaper reading
1–4.

Health education

5.

GP care

  1. Stretching
  2. Placebo pill
  3. Stretching
  4. Waitlist
1–2.

Placebo pill

  1. Advice control
Length of treatment
  1. 72 weeks
  2. 16 weeks
  3. 12 weeks
  4. 10 weeks
  5. 16 weeks
  6. 12 weeks
  1. Not reported
  2. 10 weeks
  3. 20 weeks
  4. 10 weeks
  5. 8 weeks
  1. 12 weeks
  2. 16 weeks
  3. 10 days
  4. 6 weeks
1–2.

16 weeks

  1. 10 weeks
Follow-up
1–2.

Not reported

3.

3 months

4.

Not reported

5.

8 weeks

6.

Not reported

1.

Not reported

2.

34 weeks

3.

6 weeks

4–5.

Not reported

1–4.

Not reported

1–2.

Not reported

  1. 6 months
*

3-arm trial;

4-arm trial.

From: 7, LOW-INTENSITY PSYCHOSOCIAL INTERVENTIONS

Cover of Depression
Depression: The Treatment and Management of Depression in Adults (Updated Edition).
NICE Clinical Guidelines, No. 90.
National Collaborating Centre for Mental Health (UK).
Leicester (UK): British Psychological Society; 2010.
Copyright © The British Psychological Society & The Royal College of Psychiatrists, 2010.

All rights reserved. No part of this book may be reprinted or reproduced or utilised in any form or by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying and recording, or in any information storage or retrieval system, without permission in writing from the publishers. Enquiries in this regard should be directed to the British Psychological Society.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.